Bio-Techne Corporation (TECH)
Bio-Techne Statistics
Share Statistics
Bio-Techne has 158.09M shares outstanding. The number of shares has increased by 0.32% in one year.
| Shares Outstanding | 158.09M |
| Shares Change (YoY) | 0.32% |
| Shares Change (QoQ) | -0.51% |
| Owned by Institutions (%) | 98.83% |
| Shares Floating | 156.31M |
| Failed to Deliver (FTD) Shares | 7.69K |
| FTD / Avg. Volume | 0.49% |
Short Selling Information
The latest short interest is 4.05M, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 4.05M |
| Short % of Shares Out | 2.55% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 5.32 |
Valuation Ratios
The PE ratio is 67.18 and the forward PE ratio is 33.09. Bio-Techne's PEG ratio is -1.64.
| PE Ratio | 67.18 |
| Forward PE | 33.09 |
| PS Ratio | 9.74 |
| Forward PS | 5.2 |
| PB Ratio | 5.46 |
| P/FCF Ratio | 47.83 |
| PEG Ratio | -1.64 |
Enterprise Valuation
Bio-Techne has an Enterprise Value (EV) of 11.56B.
| EV / Sales | 9.97 |
| EV / EBITDA | 37.25 |
| EV / EBIT | 38.67 |
| EV / FCF | 48.97 |
Financial Position
The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.2.
| Current Ratio | 3.87 |
| Quick Ratio | 2.75 |
| Debt / Equity | 0.2 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 1.78 |
| Interest Coverage | 13.13 |
Financial Efficiency
Return on Equity is 8.13% and Return on Invested Capital is 7.28%.
| Return on Equity | 8.13% |
| Return on Assets | 6.22% |
| Return on Invested Capital | 7.28% |
| Revenue Per Employee | $373.89K |
| Profits Per Employee | $54.23K |
| Employee Count | 3,100 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | 17.58M |
| Effective Tax Rate | 9.47% |
Stock Price Statistics
The stock price has increased by -16.64% in the last 52 weeks. The beta is 1.29, so Bio-Techne's price volatility has been higher than the market average.
| Beta | 1.29 |
| 52-Week Price Change | -16.64% |
| 50-Day Moving Average | 66.05 |
| 200-Day Moving Average | 72.23 |
| Relative Strength Index (RSI) | 33.02 |
| Average Volume (20 Days) | 1.58M |
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.16B and earned 168.1M in profits. Earnings per share was 1.07.
| Revenue | 1.16B |
| Gross Profit | 769.73M |
| Operating Income | 206.69M |
| Net Income | 168.1M |
| EBITDA | 310.37M |
| EBIT | 201.43M |
| Earnings Per Share (EPS) | 1.07 |
Balance Sheet
The company has 151.79M in cash and 419.54M in debt, giving a net cash position of -267.75M.
| Cash & Cash Equivalents | 151.79M |
| Total Debt | 419.54M |
| Net Cash | -267.75M |
| Retained Earnings | 1.33B |
| Total Assets | 2.67B |
| Working Capital | 473.38M |
Cash Flow
In the last 12 months, operating cash flow was 298.98M and capital expenditures -62.88M, giving a free cash flow of 236.1M.
| Operating Cash Flow | 298.98M |
| Capital Expenditures | -62.88M |
| Free Cash Flow | 236.1M |
| FCF Per Share | 1.5 |
Margins
Gross margin is 66.41%, with operating and profit margins of 17.83% and 14.5%.
| Gross Margin | 66.41% |
| Operating Margin | 17.83% |
| Pretax Margin | 16.02% |
| Profit Margin | 14.5% |
| EBITDA Margin | 26.78% |
| EBIT Margin | 17.83% |
| FCF Margin | 20.37% |
Dividends & Yields
TECH pays an annual dividend of $0.32, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | $0.32 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 32.65% |
| Earnings Yield | 1.49% |
| FCF Yield | 2.09% |
Analyst Forecast
The average price target for TECH is $81, which is 41.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $81 |
| Price Target Difference | 41.3% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Nov 30, 2022. It was a forward split with a ratio of 4:1.
| Last Split Date | Nov 30, 2022 |
| Split Type | forward |
| Split Ratio | 4:1 |
Scores
| Altman Z-Score | 10.34 |
| Piotroski F-Score | 7 |